open access

Vol 75, No 3 (2007)
REVIEWS
Published online: 2007-07-30
Submitted: 2013-02-22
Get Citation

Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice

Lucyna Kępka, Krzysztof Bujko
Pneumonol Alergol Pol 2007;75(3):256-260.

open access

Vol 75, No 3 (2007)
REVIEWS
Published online: 2007-07-30
Submitted: 2013-02-22

Abstract

According to the results of the metaanalyses the postoperative radiotherapy (PORT) after completely resected non-small cell lung cancer (NSCLC) is detrimental for early stages (I and II). Its role for pN2 patients is unclear. Therefore, the PORT is not recommended for patients after complete resection. However, the PORT metaanalysis raised many criticisms, because of the methodological issues and inclusion of series with outdated radiotherapy techniques. The potential advantages and disadvantages of PORT especially for stage III disease in the context of modern radiotherapy techniques and adjuvant chemotherapy regimens are discussed. Such a prospective study exploring mainly the issues of cardiac and pulmonary toxicity is currently conducted in Poland. The reasons of the common use of PORT, also for early stages of the disease, as shown by patterns of care surveys are presented in the light of the quality of surgery issues.

Abstract

According to the results of the metaanalyses the postoperative radiotherapy (PORT) after completely resected non-small cell lung cancer (NSCLC) is detrimental for early stages (I and II). Its role for pN2 patients is unclear. Therefore, the PORT is not recommended for patients after complete resection. However, the PORT metaanalysis raised many criticisms, because of the methodological issues and inclusion of series with outdated radiotherapy techniques. The potential advantages and disadvantages of PORT especially for stage III disease in the context of modern radiotherapy techniques and adjuvant chemotherapy regimens are discussed. Such a prospective study exploring mainly the issues of cardiac and pulmonary toxicity is currently conducted in Poland. The reasons of the common use of PORT, also for early stages of the disease, as shown by patterns of care surveys are presented in the light of the quality of surgery issues.
Citation Formats

Keywords

non-small cell lung cancer; postoperative radiotherapy; adjuvant chemotherapy

About this article
Title

Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice

Journal

Advances in Respiratory Medicine

Issue

Vol 75, No 3 (2007)

Pages

256-260

Published online

2007-07-30

Bibliographic record

Pneumonol Alergol Pol 2007;75(3):256-260.

Keywords

non-small cell lung cancer
postoperative radiotherapy
adjuvant chemotherapy

Authors

Lucyna Kępka
Krzysztof Bujko

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl